Cargando…
Dépistage sérologique de la maladie cœliaque chez des patients marocains atteints de diabète type 1
Celiac disease (CD) is an autoimmune disease frequently associated with type 1 diabetes (T1D). The prevalence of CD in patients with T1D varies from 3 to 6%. The clinical manifestation of CD in patients with T1D is classified as asymptomatic in about half of cases. Our study aims to determine the fr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012834/ https://www.ncbi.nlm.nih.gov/pubmed/27642442 http://dx.doi.org/10.11604/pamj.2016.24.103.8555 |
_version_ | 1782452062523490304 |
---|---|
author | Bourhanbour, Asmaa Drissi Ouadghiri, Sanae Benseffaj, Nadia Essakalli, Malika |
author_facet | Bourhanbour, Asmaa Drissi Ouadghiri, Sanae Benseffaj, Nadia Essakalli, Malika |
author_sort | Bourhanbour, Asmaa Drissi |
collection | PubMed |
description | Celiac disease (CD) is an autoimmune disease frequently associated with type 1 diabetes (T1D). The prevalence of CD in patients with T1D varies from 3 to 6%. The clinical manifestation of CD in patients with T1D is classified as asymptomatic in about half of cases. Our study aims to determine the frequency of anti-tissue transglutaminase autoantibodies (IgA-tTG) and anti-gliadin antibodies (AGA) in patients with type 1 diabetes in order to early recommend jejunal biopsy and establish a gluten-free diet before the onset of clinical signs and complications of celiac disease. Subjects included in this study were patients with T1D and untreated CD who showed no signs of this disease. The detection of IgG tTG, IgG IgA and IgG AAG was performed using Luminex technology. We enrolled 31 patients. The study involved 16 men and 15 women. IgA AAG were positive in 4(13%) patients and IgG were positive in 7(22,5%) patients. IgA tTG were positive in 3(10%) patients and IgG was positive in one (3%) patient. In our study the association of diabetes type 1 with biomarkers of CD is not uncommon hence the importance of systematic screening for type 1 diabetes. The diagnosis of this atypical and silent CD form is important given the risk of serious complications such as malabsorption and gastrointestinal cancers. |
format | Online Article Text |
id | pubmed-5012834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | The African Field Epidemiology Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-50128342016-09-16 Dépistage sérologique de la maladie cœliaque chez des patients marocains atteints de diabète type 1 Bourhanbour, Asmaa Drissi Ouadghiri, Sanae Benseffaj, Nadia Essakalli, Malika Pan Afr Med J Case Series Celiac disease (CD) is an autoimmune disease frequently associated with type 1 diabetes (T1D). The prevalence of CD in patients with T1D varies from 3 to 6%. The clinical manifestation of CD in patients with T1D is classified as asymptomatic in about half of cases. Our study aims to determine the frequency of anti-tissue transglutaminase autoantibodies (IgA-tTG) and anti-gliadin antibodies (AGA) in patients with type 1 diabetes in order to early recommend jejunal biopsy and establish a gluten-free diet before the onset of clinical signs and complications of celiac disease. Subjects included in this study were patients with T1D and untreated CD who showed no signs of this disease. The detection of IgG tTG, IgG IgA and IgG AAG was performed using Luminex technology. We enrolled 31 patients. The study involved 16 men and 15 women. IgA AAG were positive in 4(13%) patients and IgG were positive in 7(22,5%) patients. IgA tTG were positive in 3(10%) patients and IgG was positive in one (3%) patient. In our study the association of diabetes type 1 with biomarkers of CD is not uncommon hence the importance of systematic screening for type 1 diabetes. The diagnosis of this atypical and silent CD form is important given the risk of serious complications such as malabsorption and gastrointestinal cancers. The African Field Epidemiology Network 2016-05-31 /pmc/articles/PMC5012834/ /pubmed/27642442 http://dx.doi.org/10.11604/pamj.2016.24.103.8555 Text en © Asmaa Drissi Bourhanbour et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Series Bourhanbour, Asmaa Drissi Ouadghiri, Sanae Benseffaj, Nadia Essakalli, Malika Dépistage sérologique de la maladie cœliaque chez des patients marocains atteints de diabète type 1 |
title | Dépistage sérologique de la maladie cœliaque chez des patients marocains atteints de diabète type 1 |
title_full | Dépistage sérologique de la maladie cœliaque chez des patients marocains atteints de diabète type 1 |
title_fullStr | Dépistage sérologique de la maladie cœliaque chez des patients marocains atteints de diabète type 1 |
title_full_unstemmed | Dépistage sérologique de la maladie cœliaque chez des patients marocains atteints de diabète type 1 |
title_short | Dépistage sérologique de la maladie cœliaque chez des patients marocains atteints de diabète type 1 |
title_sort | dépistage sérologique de la maladie cœliaque chez des patients marocains atteints de diabète type 1 |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012834/ https://www.ncbi.nlm.nih.gov/pubmed/27642442 http://dx.doi.org/10.11604/pamj.2016.24.103.8555 |
work_keys_str_mv | AT bourhanbourasmaadrissi depistageserologiquedelamaladiecœliaquechezdespatientsmarocainsatteintsdediabetetype1 AT ouadghirisanae depistageserologiquedelamaladiecœliaquechezdespatientsmarocainsatteintsdediabetetype1 AT benseffajnadia depistageserologiquedelamaladiecœliaquechezdespatientsmarocainsatteintsdediabetetype1 AT essakallimalika depistageserologiquedelamaladiecœliaquechezdespatientsmarocainsatteintsdediabetetype1 |